sb.scorecardresearch
Advertisement

Published 13:51 IST, September 10th 2020

COVID-19 vaccine: Bharat Biotech's COVAXIN begins Phase 2 of human trials at PGI Rohtak

The phase 2 of the human clinical trial of Bharat Biotech's COVAXIN, India’s first indigenously developed vaccine against COVID-19, began at PGIMS Rohtak

Reported by: Gloria Methri
Follow: Google News Icon
  • share
COVID-19
null | Image: self
Advertisement

13:51 IST, September 10th 2020